A COST-CONSEQUENCE ANALYSIS OF HUMAN PAPILLOMAVIRUS VACCINATION IN ROMANIA

被引：0
|
作者：
Preda, A. L. [1 ]
Moise, M. [1 ]
Van Kriekinge, G. [2 ]
机构：
[1] GlaxoSmithKline, Bucharest, Romania
[2] GlaxoSmithKline Vaccines, Wavre, Belgium
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 07期
关键词：
D O I：
10.1016/j.jval.2014.08.2256
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN98
引用
收藏
页码：A631 / A631
页数：1
相关论文
共 50 条
  • [21] Cost-consequence analysis of salvianolate injection for the treatment of coronary heart disease
    Pengxin Dong
    Hao Hu
    Xiaodong Guan
    Carolina Oi Lam Ung
    Luwen Shi
    Sheng Han
    Shuwen Yu
    [J]. Chinese Medicine, 13
  • [22] OVERVIEW OF COST-CONSEQUENCE MODELING IN OUTCOMES RESEARCH
    STERGACHIS, A
    [J]. PHARMACOTHERAPY, 1995, 15 (05): : S40 - S42
  • [23] A cost-consequence analysis of a menu intervention in early childhood education and care
    Kurkela, Olli
    Virtanen, S. M.
    Erkkola, M.
    Saarinen, M.
    Niinisto, S.
    Raulio, S.
    Ahokas, I.
    Meinila, J.
    Forma, L.
    [J]. EUROPEAN JOURNAL OF PUBLIC HEALTH, 2023, 33
  • [24] Cost-Consequence Analysis of Advanced Imaging in Acute Ischemic Stroke Care
    Boltyenkov, Artem T.
    Martinez, Gabriela
    Pandya, Ankur
    Katz, Jeffrey M.
    Wang, Jason J.
    Naidich, Jason J.
    Rula, Elizabeth
    Sanelli, Pina C.
    [J]. FRONTIERS IN NEUROLOGY, 2021, 12
  • [25] COST-CONSEQUENCE ANALYSIS OF CSII VS. MDI: A CANADIAN PERSPECTIVE
    Sadri, H.
    Bereza, B. G.
    Longo, C. J.
    [J]. VALUE IN HEALTH, 2010, 13 (07) : A290 - A290
  • [26] Evaluating stroke early supported discharge using cost-consequence analysis
    Byrne, Adrian
    Chouliara, Niki
    Cameron, Trudi
    Geue, Claudia
    Lewis, Sarah
    Robinson, Thompson
    Langhorne, Peter
    Walker, Marion F.
    Fisher, Rebecca J.
    [J]. DISABILITY AND REHABILITATION, 2022, 44 (23) : 7127 - 7133
  • [27] Re: Cost-Effectiveness Analysis of Human Papillomavirus Vaccination in the Netherlands
    Coupe, Veerle M. H.
    Meijer, Chris J. L. M.
    Berkhof, Johannes
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2010, 102 (05)
  • [28] COST-EFFECTIVENESS ANALYSIS OF HUMAN PAPILLOMAVIRUS VACCINATION PROGRAM IN RUSSIA
    Omelyanovsky, V
    Avxentyeva, M.
    Krysanov, I
    Ivakhnenko, O.
    Goryaynov, S.
    Tsfasman, F. M.
    [J]. VALUE IN HEALTH, 2011, 14 (07) : A277 - A278
  • [29] Cost of a human papillomavirus vaccination project, Zimbabwe
    Hidle, Anna
    Gwati, Gwati
    Abimbola, Taiwo
    Pallas, Sarah W.
    Hyde, Terri
    Petu, Amos
    McFarland, Deborah
    Manangazira, Portia
    [J]. BULLETIN OF THE WORLD HEALTH ORGANIZATION, 2018, 96 (12) : 834 - 842
  • [30] COMPARATIVE COST-CONSEQUENCE ANALYSIS OF THE BIVALENT AND QUADRIVALENT VACCINES AGAINST HPV IN SPAIN
    Lopez Belmonte, J. L.
    Cortes Bordoy, J.
    Gil de Miguel, A.
    Bresse, X.
    Serip, S.
    Nieves, D.
    Bosch, X.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A408 - A408
12345